🌙
Average Insider
Where insiders trade, we follow
🔍
☰
🏠 Home
🔍 Search
🏢 Companies
📊 Cluster Buys
📄 Filings Search
💰 Earnings Calendar
📧 Newsletters
📝 Sign Up
🔐 Sign In
Buy/Sell Ratio
›
March 2026
›
Healthcare Sector
Insider Buy/Sell Details for the Healthcare Sector — March 2026
Extreme outlier transactions (>3σ) are excluded.
Show All Data
Ratio
0.1:1
Daily Buy & Sell Volume
Log Scale
Transactions
(2118)
All (2118)
Buys (184)
Sells (1934)
Company
Insider
Title
Sort by
Date (newest)
Total Value
% of Holdings
Company Name
Apply
GRAIL, Inc.
(GRAL)
RAGUSA ROBERT P
— Director
Mar 9, 2026
Sale
Shares
258
Price
$46.73
Total Value
$12.06K
Shares Held After
642,084
% of Holdings
0.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
GRAIL, Inc.
(GRAL)
RAGUSA ROBERT P
— Director
Mar 9, 2026
Sale
Shares
7,203
Price
$47.93
Total Value
$345.24K
Shares Held After
642,342
% of Holdings
1.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
GRAIL, Inc.
(GRAL)
Ofman Joshua J.
— President
Mar 9, 2026
Sale
Shares
101
Price
$46.74
Total Value
$4.72K
Shares Held After
432,881
% of Holdings
0.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
GRAIL, Inc.
(GRAL)
Ofman Joshua J.
— President
Mar 9, 2026
Sale
Shares
2,836
Price
$47.93
Total Value
$135.93K
Shares Held After
432,982
% of Holdings
0.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
CERUS CORP
(CERS)
Benjamin Richard J
— Chief Medical Officer
Mar 9, 2026
Sale
Shares
40,426
Price
$1.88
Total Value
$76.03K
Shares Held After
879,101
% of Holdings
4.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
U S PHYSICAL THERAPY INC /NV
(USPH)
REEVE GRAHAM D.
— COO
Mar 6, 2026
Sale
Shares
1,807
Price
$82.25
Total Value
$148.63K
Shares Held After
1
% of Holdings
99.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Indivior Pharmaceuticals, Inc.
(INDV)
Kingsley Stuart A
— Director
Mar 6, 2026
Purchase
Shares
940
Price
$31.86
Total Value
$29.95K
Shares Held After
5,582
% of Holdings
16.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 6, 2026
Sale
Shares
160
Price
$484.27
Total Value
$77.48K
Shares Held After
130
% of Holdings
55.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 6, 2026
Sale
Shares
450
Price
$483.69
Total Value
$217.66K
Shares Held After
290
% of Holdings
60.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 6, 2026
Sale
Shares
200
Price
$482.74
Total Value
$96.55K
Shares Held After
740
% of Holdings
21.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 6, 2026
Sale
Shares
240
Price
$481.59
Total Value
$115.58K
Shares Held After
940
% of Holdings
20.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 6, 2026
Sale
Shares
938
Price
$480.47
Total Value
$450.68K
Shares Held After
1,180
% of Holdings
44.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 6, 2026
Sale
Shares
582
Price
$479.63
Total Value
$279.14K
Shares Held After
2,118
% of Holdings
21.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 6, 2026
Sale
Shares
1,212
Price
$478.32
Total Value
$579.72K
Shares Held After
2,700
% of Holdings
31.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 6, 2026
Sale
Shares
2,194
Price
$477.53
Total Value
$1.05M
Shares Held After
3,912
% of Holdings
35.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 6, 2026
Sale
Shares
880
Price
$476.37
Total Value
$419.20K
Shares Held After
6,106
% of Holdings
12.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 6, 2026
Sale
Shares
1,118
Price
$475.36
Total Value
$531.45K
Shares Held After
6,986
% of Holdings
13.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 6, 2026
Sale
Shares
1,001
Price
$474.12
Total Value
$474.60K
Shares Held After
8,104
% of Holdings
11.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 6, 2026
Sale
Shares
241
Price
$473.23
Total Value
$114.05K
Shares Held After
9,105
% of Holdings
2.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 6, 2026
Sale
Shares
284
Price
$471.96
Total Value
$134.04K
Shares Held After
9,346
% of Holdings
2.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Twist Bioscience Corp
(TWST)
Green Paula
— SVP of Human Resources
Mar 6, 2026
Sale
Shares
935
Price
$46.43
Total Value
$43.41K
Shares Held After
124,401
% of Holdings
0.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Bausch & Lomb Corp
(BLCO)
Bailey A Robert D
— EVP & Chief Legal Officer
Mar 6, 2026
Purchase
Shares
14,600
Price
$17.15
Total Value
$250.33K
Shares Held After
231,890
% of Holdings
6.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Sotera Health Co
(SHC)
WARBURG PINCUS & CO.
— Director
Mar 6, 2026
Sale
Shares
15,000,000
Price
$15.27
Total Value
$229.05M
Shares Held After
19,102,952
% of Holdings
44.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Bausch & Lomb Corp
(BLCO)
SAUNDERS BRENT L
— Director
Mar 6, 2026
Purchase
Shares
14,700
Price
$17.14
Total Value
$251.96K
Shares Held After
966,575
% of Holdings
1.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Nuvalent, Inc.
(NUVL)
Porter James Richard
— Director
Mar 6, 2026
Sale
Shares
400
Price
$100.19
Total Value
$40.08K
Shares Held After
324,879
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Nuvalent, Inc.
(NUVL)
Porter James Richard
— Director
Mar 6, 2026
Sale
Shares
16,015
Price
$99.29
Total Value
$1.59M
Shares Held After
325,279
% of Holdings
4.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Nuvalent, Inc.
(NUVL)
Porter James Richard
— Director
Mar 6, 2026
Sale
Shares
13,585
Price
$98.59
Total Value
$1.34M
Shares Held After
341,294
% of Holdings
3.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Twist Bioscience Corp
(TWST)
Cho Dennis
— Senior Vice President, Chief Legal Officer & Corporate Secretary
Mar 6, 2026
Sale
Shares
425
Price
$46.43
Total Value
$19.73K
Shares Held After
138,257
% of Holdings
0.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Bausch & Lomb Corp
(BLCO)
Eldessouky Sam
— EVP and CFO
Mar 6, 2026
Purchase
Shares
4,000
Price
$17.13
Total Value
$68.52K
Shares Held After
403,130
% of Holdings
1.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Sotera Health Co
(SHC)
WARBURG PINCUS & CO.
— Director
Mar 6, 2026
Sale
Shares
15,000,000
Price
$15.27
Total Value
$229.05M
Shares Held After
19,102,952
% of Holdings
44.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Delcath Systems, Inc.
(DCTH)
Pennell Sandra
— Chief Financial Officer
Mar 6, 2026
Purchase
Shares
5,533
Price
$9.04
Total Value
$50.02K
Shares Held After
77,018
% of Holdings
7.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Acumen Pharmaceuticals, Inc.
(ABOS)
Meisner Derek M
— Chief Legal Officer & Corp Sec
Mar 6, 2026
Sale
Shares
2,090
Price
$3.26
Total Value
$6.81K
Shares Held After
173,999
% of Holdings
1.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
NewAmsterdam Pharma Co N.V.
(NAMS)
LANGE LOUIS G
— Director
Mar 6, 2026
Sale
Shares
28,186
Price
$29.41
Total Value
$828.95K
Shares Held After
0
% of Holdings
100.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Natera, Inc.
(NTRA)
RABINOWITZ DANIEL
— SEC. AND CHIEF LEGAL OFFICER
Mar 6, 2026
Sale
Shares
1,998
Price
$198.04
Total Value
$395.69K
Shares Held After
233,285
% of Holdings
0.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Natera, Inc.
(NTRA)
RABINOWITZ DANIEL
— SEC. AND CHIEF LEGAL OFFICER
Mar 6, 2026
Sale
Shares
1,500
Price
$196.94
Total Value
$295.41K
Shares Held After
235,283
% of Holdings
0.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Natera, Inc.
(NTRA)
RABINOWITZ DANIEL
— SEC. AND CHIEF LEGAL OFFICER
Mar 6, 2026
Sale
Shares
1,600
Price
$195.80
Total Value
$313.27K
Shares Held After
236,783
% of Holdings
0.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Natera, Inc.
(NTRA)
RABINOWITZ DANIEL
— SEC. AND CHIEF LEGAL OFFICER
Mar 6, 2026
Sale
Shares
2,900
Price
$194.77
Total Value
$564.83K
Shares Held After
238,383
% of Holdings
1.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Natera, Inc.
(NTRA)
RABINOWITZ DANIEL
— SEC. AND CHIEF LEGAL OFFICER
Mar 6, 2026
Sale
Shares
400
Price
$193.73
Total Value
$77.49K
Shares Held After
241,283
% of Holdings
0.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Adaptive Biotechnologies Corp
(ADPT)
RUBINSTEIN JULIE
— President and COO
Mar 6, 2026
Sale
Shares
30,941
Price
$15.14
Total Value
$468.45K
Shares Held After
652,147
% of Holdings
4.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Alphatec Holdings, Inc.
(ATEC)
Hunsaker Craig E
— EVP, PEOPLE & CULTURE
Mar 6, 2026
Sale
Shares
33,602
Price
$12.22
Total Value
$410.62K
Shares Held After
1,808,974
% of Holdings
1.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
SS Innovations International, Inc.
(SSII)
Sudhir Srivastava
— Director
Mar 6, 2026
Purchase
Shares
498,753
Price
$4.01
Total Value
$2.00M
Shares Held After
109,851,767
% of Holdings
0.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
SS Innovations International, Inc.
(SSII)
Adams Timothy P.
— Director
Mar 6, 2026
Purchase
Shares
300,000
Price
$3.99
Total Value
$1.20M
Shares Held After
5,331,902
% of Holdings
5.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Sotera Health Co
(SHC)
GTCR INVESTMENT XI LLC
— Director
Mar 6, 2026
Sale
Shares
10,000,000
Price
$15.27
Total Value
$152.70M
Shares Held After
12,735,301
% of Holdings
44.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
SS Innovations International, Inc.
(SSII)
MOLL FREDERIC H
— Director
Mar 6, 2026
Purchase
Shares
501,253
Price
$3.99
Total Value
$2.00M
Shares Held After
10,775,485
% of Holdings
4.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Enliven Therapeutics, Inc.
(ELVN)
Hohl Benjamin
— CHIEF FINANCIAL OFFICER
Mar 6, 2026
Sale
Shares
10,000
Price
$29.58
Total Value
$295.84K
Shares Held After
51,000
% of Holdings
16.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Ultragenyx Pharmaceutical Inc.
(RARE)
Parschauer Karah Herdman
— EVP and Chief Legal Officer
Mar 6, 2026
Sale
Shares
6,018
Price
$21.40
Total Value
$128.79K
Shares Held After
70,328
% of Holdings
7.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Dyne Therapeutics, Inc.
(DYN)
Posner Brian S
— Director
Mar 6, 2026
Purchase
Shares
3,000
Price
$15.06
Total Value
$45.18K
Shares Held After
11,500
% of Holdings
26.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Twist Bioscience Corp
(TWST)
WERNER ROBERT F.
— Chief Accounting Officer
Mar 6, 2026
Sale
Shares
246
Price
$46.43
Total Value
$11.42K
Shares Held After
54,799
% of Holdings
0.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Twist Bioscience Corp
(TWST)
Leproust Emily M.
— Director
Mar 6, 2026
Sale
Shares
2,423
Price
$46.43
Total Value
$112.49K
Shares Held After
860,629
% of Holdings
0.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ANI PHARMACEUTICALS INC
(ANIP)
Davis Krista
— SVP, CHIEF HR OFFICER
Mar 6, 2026
Sale
Shares
1,485
Price
$75.00
Total Value
$111.38K
Shares Held After
57,033
% of Holdings
2.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
← Previous
Next →
Showing 851–900 of 2118 transactions (page 18 of 43)
Version: v26.3.33